Fairvoy Private Wealth LLC Sells 5,019 Shares of Doximity, Inc. (NASDAQ:DOCS)

Fairvoy Private Wealth LLC decreased its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 26.9% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,611 shares of the company's stock after selling 5,019 shares during the quarter. Fairvoy Private Wealth LLC's holdings in Doximity were worth $790,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Global Retirement Partners LLC raised its position in Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after acquiring an additional 440 shares in the last quarter. Larson Financial Group LLC lifted its stake in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the last quarter. Optimum Investment Advisors acquired a new stake in Doximity in the 4th quarter valued at about $43,000. Kapitalo Investimentos Ltda bought a new position in Doximity during the fourth quarter worth about $50,000. Finally, Huntington National Bank increased its position in Doximity by 1,440.8% during the fourth quarter. Huntington National Bank now owns 1,094 shares of the company's stock worth $58,000 after buying an additional 1,023 shares during the last quarter. Institutional investors own 87.19% of the company's stock.

Insider Buying and Selling

In other news, CFO Anna Bryson sold 45,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the transaction, the chief financial officer now directly owns 357,165 shares in the company, valued at approximately $20,440,552.95. This represents a 11.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $56.93, for a total value of $113,860.00. Following the completion of the transaction, the director now directly owns 16,618 shares of the company's stock, valued at approximately $946,062.74. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 51,000 shares of company stock worth $2,900,770 in the last ninety days. 37.40% of the stock is owned by insiders.

Doximity Stock Down 2.4%

Shares of DOCS traded down $1.41 during trading hours on Wednesday, hitting $57.10. 1,996,249 shares of the company were exchanged, compared to its average volume of 2,142,378. The company has a market cap of $10.72 billion, a price-to-earnings ratio of 57.10, a P/E/G ratio of 4.10 and a beta of 1.32. The firm's fifty day moving average is $55.30 and its 200 day moving average is $58.52. Doximity, Inc. has a fifty-two week low of $25.00 and a fifty-two week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its earnings results on Thursday, May 15th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.27 by $0.11. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The firm's quarterly revenue was up 17.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.25 earnings per share. Analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Raymond James Financial cut their price objective on Doximity from $83.00 to $65.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Robert W. Baird cut their price target on Doximity from $87.00 to $65.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. The Goldman Sachs Group set a $50.00 price objective on shares of Doximity and gave the company a "neutral" rating in a report on Wednesday, May 21st. Needham & Company LLC cut their target price on shares of Doximity from $82.00 to $67.00 and set a "buy" rating for the company in a research note on Friday, May 16th. Finally, BTIG Research upgraded shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 price target on the stock in a research note on Monday, June 2nd. Eleven equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Doximity has an average rating of "Moderate Buy" and an average price target of $62.84.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.